Back to News
Market Impact: 0.2
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Source: TechCrunch
Healthcare & BiotechTechnology & InnovationRegulation & Legislation
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing. The startup is seeking to scale production and expand its organoid technology; the article provides no financial figures or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- SK Hynix plunges 8% amid Asia tech rout as Fed rate hike fears, AI funding worries mount
- Why is Samsung Electronics stock plunging today?
- Why is Advantest stock plummeting today?
- Japan, U.S. reach first chip deal under $550 bln investment plan
- Elon Musk says Trump is 'ultimately' responsible for any curbs on Ukraine's Starshield systems
- SK Hynix seeks U.S. chip equipment exports to China tied to new factory